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Abstract
Peri-implantitis and periodontitis
Experimental and clinical studies
Olivier Carcuac
Department of  Periodontology, Institute of  Odontology, the Sahlgrenska Academy at University of  
Gothenburg
Peri-implantitis is an increasing problem in implant dentistry. The current series of studies employed 
a translational approach with the aim to compare peri-implantitis and periodontitis lesions and 
evaluate the influence of implant surface characteristics and the adjunctive use of systemic 
antibiotics/local antiseptics on healing following surgical treatment of  peri-implantitis.
Tissue reactions following ligature removal in experimental periodontitis and peri-implantitis were 
analyzed in a dog model (Study I). Histopathological characteristics in human peri-implantitis and 
periodontitis lesions were evaluated  in 80 patients (Study II). Labrador dogs were used to analyze 
the effect of surgical treatment of experimental peri-implantitis at implants with different surface 
characteristics using different anti-infective procedures (Study III). 100 patients with severe peri-
implantitis were treated surgically with or without adjunctive systemic antibiotics or the local use of 
chlorhexidine for implant surface decontamination. Treatment outcomes were evaluated after 1 year. 
A binary logistic regression analysis was performed to identify factors influencing the probability of 
treatment success (Study IV).
It was demonstrated that :
- the amount of bone loss that occurred during the period following ligature removal was 
significantly larger at implants with a modified surface than at  implants with a non-modified sur-
face and at teeth. The histological analysis revealed  that peri-implantitis sites exhibited inflamma-
tory cell infiltrates that were larger, extended closer to the bone crest and contained larger propor-
tions of  neutrophil granulocytes and osteoclasts than in periodontitis. (Study I)
- peri-implantitis lesions were more than twice as large and contained significantly larger area pro-
portions, numbers, and densities of CD138-, CD68-, and MPO-positive cells than periodontitis 
lesions. (Study II)
- the local use of chlorhexidine has minor influence on resolution of peri-implantitis following sur-
gical treatment. (Study III)
- treatment outcome was influenced by implant surface characteristics. (Study III and IV)
- the adjunctive use of systemic antibiotics increased the probability for treatment success at im-
plants with modified surfaces but not at implants with a non-modified surface. (Study IV)
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List of  abbreviations
Common abbreviations used in this thesis are listed according to their first appearance.
ICT Inflamed connective tissue AB Systemic antibiotics
PMN Polymorphonuclear cell AS Local antiseptics
IL-1 Interleukine 1 CVD Cardiovascular disease
IL-6 Interleukine 6 GM/PM Gingival/peri-implant mucosa margin
TNF-⍺ Tumor necrosis factor- alpha A/F Abutment/fixture junction
IL-8 Interleukine 8 CEJ Cemento-enamel junction
PIM Peri-implant mucosa aPlaque Apical termination of  the biofilm
CT Connective tissue aPE Apical termination of  the pocket epithelium
PE Pocket epithelium B Marginal bone level closest to tooth/implant
PI Peri-implantitis BC Most coronal extension of  the bone crest
AG Aggressive periodontitis cICT Coronal extension of  the ICT
CP Chronic periodontitis aICT Apical extension of  the ICT
PPD Probing pocket depth Bw Lateral bone wall of  the intra-bony defect
BoP Bleeding on probing AGNB Aerobie gram negative bacilli
IHC Immunohistochemical MPO Myeloperoxydase
CAL Clinical attachment loss IgG Immunoglobuline G
e-PTFE Expanded polytetrafluoroethylene TVC Total viable count
SLA Sandblasted large acid-etched OR Odds ratio
TPS Titanium plasma sprayed
Er-YAG Erbium doped yttrium-aluminium-granet
Dnr Diarienumber
NP Narrow platform
S.D. Standard deviation
SoP Suppuration on probing
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Introduction
Peri-implantitis is defined as inflammation in peri-implant soft tissues and associated loss 
of supporting bone (Lindhe & Meyle, 2008). Several reviews have tried to assess the 
prevalence of peri-implantitis (Zitzmann & Berglundh, 2008; Mombelli et al., 2012; Derks 
& Tomasi, 2014) and data from cross-sectional studies of different patient groups (Frans-
son et al., 2005; 2008; Ferreira et al., 2006; Roos Jansåker et al., 2006; Koldsland et al., 
2010; Zetterqvist et al., 2010; Dvorak et al., 2011; Mir-Mari et al., 2012; Casado et al., 2013; 
Marrone et al., 2013; Cecchinato et al., 2013, 2014) revealed that the prevalence of peri-
implantitis ranged from 1 % to 47 %. Tomasi & Derks (2012) addressed the complexity of 
case definitions in the literature, which, may explain the large variation in prevalence of 
peri-implant diseases reported in different studies. Such a limitation together with varying 
time of follow-up were considered in a systematic review  by Derks & Tomasi (2014). 
Meta-analysis revealed an estimated weighted mean prevalence for peri-implantitis of 22 % 
(95 % CI: 14 %-30 %).
Peri-implantitis and periodontitis lesions
Although clinical and radiological signs of periodontitis and peri-implantitis have many 
features in common, results from pre-clinical in vivo studies indicate that significant histo-
pathological differences exist, which may explain differences in disease onset and progres-
sion (Lindhe et al., 1992; Schou et al., 1993; Berglundh et al., 2011). In a review  on perio-
dontitis and peri-implantitis lesions, Berglundh et al. (2011) appraised information on the 
different lesions. The authors reported that few  pre-clinical in  vivo studies comparing ex-
perimental ligature-induced peri-implantitis and periodontitis lesions in animals were avail-
able (Table 1) and that studies including structured comparisons between human peri-
implantitis and periodontitis lesions were lacking (Table 2).
Pre-clinical in vivo studies in animals
Most experimental studies on peri-implantitis used the ligature-model to induce break-
down of peri-implant soft and hard tissues. This model was extensively used in studies on 
experimental periodontitis and was introduced to promote rapid tissue breakdown as op-
posed to earlier studies on the natural development of periodontitis in dogs with attach-
ment and bone loss occurring after several years (Lindhe et al., 1973, 1975; Hamp & Lind-
berg, 1977). Thus, ligatures were used together with plaque formation in order to initiate 
and maintain a pathological process in gingival tissues. Placement of a ligature in a subgin-
gival position disrupts the soft tissue seal around teeth and implants and opens the pocket 
for biofilm accumulation. While a ligature made of cotton or silk may not induce bone 
loss by itself, the developing inflammatory process in the connective tissue that results 
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from biofilm formation mediates tissue destruction during the experiment. The early 
response to ligature placement and biofilm accumulation in experimental periodontitis was 
described in a study in monkeys (Heijl et al., 1976). It was observed that the rate of tissue 
breakdown decreased over time and that ligatures had to be removed and replaced to 
promote continuous tissue destruction. In most studies on experimental periodontitis, 
ligatures were removed about one month prior to biopsy to allow  acute lesions to become 
chronic. Using a similar procedure in experimental peri-implantitis, results indicated that 
the spontaneous resolution observed in experimental periodontitis sites did not occur after 
ligature removal around implants (Lindhe et al., 1992). In this study, cotton ligatures were 
placed in a subgingival position around teeth and implants in five beagle dogs and plaque 
was allowed to accumulate. While the ligatures were removed after 6 weeks, plaque forma-
tion continued and after an additional 4-week period clinical and radiological examinations 
were performed and block biopsies were obtained. It was reported that clinical signs of 
inflammation and radiographic bone loss was more pronounced in peri-implantitis than in 
periodontitis sites. In addition, the histological examination revealed that the inflamed 
connective tissue (ICT) was larger at implants than at teeth. It was observed that peri-
implantitis lesions extended to the bone crest, while the periodontitis lesions were consis-
tently separated from the bone crest by a zone of non inflamed connective tissue. Similar 
findings were presented by Schou et al. (1993) studying experimental peri-implantitis and 
periodontitis in monkeys. It was reported that bone loss was more pronounced around 
implants than at teeth and that bone loss was associated with a high number of osteoclasts 
in the histological specimens.
A new  approach to the ligature-model was introduced by Zitzmann et al. (2004). Ligatures 
were placed in a submarginal position around Brånemark implants in 5 Labrador dogs. 
The combination of the local trauma elicited by the ligatures and concomitant plaque ac-
cumulation resulted in bone defects and clinical signs of inflammation around all implants. 
The ligatures were removed and during the subsequent 1-year period of continuous plaque 
formation, additional bone loss occurred around several implants. It was concluded that 
spontaneous progression of peri-implantitis may occur after the removal of ligatures. This 
model of “spontaneous progression in experimental peri-implantitis”	   was subsequently 
applied by Berglundh et al. (2007) and Albouy et al. (2008, 2009, 2012). Similar observa-
tions of a continuous destructive process following removal of ligatures have not been 
reported in experimental periodontitis. 
Using the same ligature-model and sampling of biopsies that included the entire peri-
implant and periodontal hard and soft tissue components, a pre-clinical in vivo model was 
used in study I to evaluate differences in tissue reactions in experimentally induced perio-
dontitis and peri-implantitis in dogs.
Introduction
16
Human biopsy material
As findings from experimental studies should be validated in human protocols and more 
comprehensive analyses of cellular and functional characteristics of the lesions are re-
quired, evaluations of human biopsies are needed. In the abovementioned review  on 
periodontitis and peri-implantitis lesions, Berglundh et al. (2011) reported that compre-
hensive information on human periodontitis lesions exists, while few studies have 
examined peri-implantitis lesions prepared from human samples (Sanz et al., 1991; Corne-
lini et al., 2001; Gualini & Berglundh, 2003; Berglundh et al., 2004). In addition, the analy-
ses of  human peri-implantitis were based on small samples. 
Sanz et al. (1991) analyzed soft tissue biopsies from 6 patients with peri-implantitis and 
reported that about 2/3 of the connective tissue portion of the biopsy was occupied by an 
infiltrate consisting of plasma cells, mononuclear cells and enlarged blood vessels. Similar 
findings were presented by Cornelini et al. (2001) in a study on biopsies prepared from 10 
patients with peri-implantitis. Gualini & Berglundh (2003) examined immunohistochemical 
characteristics of soft tissue biopsies obtained from 16 patients and reported that peri-
implantitis lesions were considerably larger and contained significantly greater proportions 
of B cells and elastase-positive cells than mucositis lesions. Berglundh et al. (2004) ana-
lyzed soft tissue biopsies obtained from 12 implants with severe peri-implantitis in 6 pa-
tients. The histological analysis demonstrated that lesions occupied almost the entire con-
nective tissue compartment and extended apically of  the pocket epithelium.  
Comparisons between human peri-implantitis and periodontitis lesions are rare. Bullon et 
al. (2004) analyzed soft tissue biopsies from 5 cases with peri-implantitis and 5 patients 
with aggressive periodontitis. It was reported that both peri-implantitis and periodontitis 
lesions presented with plasma cells, macrophages and lymphocytes, among which T cells 
were more common than B cells. Konttinen et al. (2006) analyzed Il-1, IL-6, TNF-⍺ in 
peri-implant and/or gingival samples from failing implants, chronic periodontitis and 
healthy gingiva and reported that cytokines with a potential to activate osteoclasts were 
found in both peri-implantitis and chronic periodontitis with a higher proportions of IL-1 
and IL-6 in peri-implantitis than in periodontitis lesions. Venza et al. (2010) analyzed soft 
tissue biopsies collected from different patient-groups and reported that peri-implantitis 
specimens exhibited higher mRNA expression of IL-6, IL-8, and TNF-⍺ than periodonti-
tis samples. In a study on genome-wide transcriptome profiles in gingival specimens ob-
tained from small patient groups with periodontitis and peri-implantitis, Becker et al. 
(2014) concluded that the two conditions represent distinct entities with different mRNA 
signatures.
Comparisons between human peri-implantitis and periodontitis lesions require sufficiently 
powered patient samples to unravel critical differences between the conditions. Thus, 
study II was performed to compare local host response characteristics in peri-implantitis 
and periodontitis in humans at the cellular level.
Introduction
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Treatment of  peri-implantitis
The primary goals of treatment of peri-implantitis are to resolve inflammation and to 
arrest the progression of disease. As the aetiology of peri-implantitis is similar to that of 
periodontitis, anti-infective protocols comparable to those used in the treatment of perio-
dontitis should be adopted to treat peri-implantitis (Lindhe & Meyle, 2008). Thus, decon-
tamination of the implant surface is considered as a priority for the treatment of peri-
implantitis. Treatment protocols have often included surgical access to implants presenting 
with peri-implantitis and numerous protocols including different chemical detergents, air-
powder abrasive devices or lasers, have been presented to achieve decontamination of 
implant surfaces. (Claffey et al., 2008)
Pre-clinical in vivo studies in animals
Pre-clinical in vivo studies on treatment of experimentally induced peri-implantitis have 
demonstrated that resolution of peri-implantitis lesions is possible. Animal models of 
experimental peri-implantitis have been useful for evaluation of various implant surface 
decontamination protocols in the surgical treatment of peri-implantitis (Table 3). 
Numerous implant surface decontamination methods as part of the surgical treatment of 
peri-implantitis have been suggested, either alone or in different combinations, but no 
single decontamination procedure was found to be superior. Schou et al. (2003) compared 
4 methods in a monkey model: (1) air-powder abrasive technique followed by citric acid 
application, (2) air-powder abrasive technique alone, (3) gauze soaked in saline followed by 
citric acid application, and (4) gauze soaked alternately in a 0.1 % solution of chlor-
hexidine digluconate and saline. Experimental peri-implant defects, created over a period 
of 9 to 17 months around implants with a TPS surface, were surgically exposed. Each 
implant surface was subjected to one of the previously mentioned treatment procedures. 
All defects were filled with autogenous bone graft particles and covered by an e-PTFE 
membrane. Clinical parameters, radiological assessments, histological, and stereological 
analyses did not reveal significant differences between any of the methods used. It was 
concluded that for implants with a modified surface, the simplest method, i.e., gauze 
soaked alternately in chlorhexidine and saline, should be the preferred implant surface 
decontamination method when combined with membrane-covered autogenous bone graft 
particles. 
Other pre-clinical in vivo studies confirmed that resolution of peri-implantitis lesions is 
possible at implants with modified surfaces by decontamination with gauze soaked in sa-
line (Persson et al., 1999; Persson et al., 2001; Albouy et al., 2011). Albouy et al. (2011), in 
an experimental study in dogs, reported on the outcome of treatment of peri-implantitis 
using gauze soaked in saline in the absence of systemic antibiotics. It was concluded that 
resolution of peri-implantitis following treatment without systemic antibiotics or local 
antiseptic was possible. However, it was also demonstrated that implant surface 
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characteristics influenced treatment outcomes with a poorer results at implants with a 
porous anodized surface (TiUnite) when compared to implants with turned, TiOblast and 
SLA surfaces.
In study III, using a pre-clinical in  vivo dog model, appropriate radiological, histological 
and microbiological methods were applied to evaluate resolution of peri-implantitis 
following surgical treatment at implants with different surface characteristics.	  
 
Clinical studies
Prospective studies evaluating outcomes of surgical therapy of peri-implantitis with a 
follow-up period of at least 1 year, and aiming at comparing different methods of implant-
surface decontamination are few. (Table 4)
Although several surgical protocols for treating peri-implantitis have been applied in many 
case series, there are few randomized controlled trials using a define control treatment. 
Most studies focused on outcomes of reconstructive procedures comparing different 
types of reconstructive techniques, different grafting materials and the use of membranes 
(Schwarz et al., 2006, 2008, 2009; Deppe et al., 2007; Roos Jansåker et al., 2007, 2011, 
2014; Romanos & Nentwig, 2009; Aghazadeh et al., 2012). Khoshkam et al. (2013), in a 
review, concluded that there was currently no evidence of additional benefit of recon-
structive procedures over other treatment modalities for managing peri-implantitis. Only 
few studies have investigated the effect of access flap surgery combined with debridement 
and implant surface decontamination (Leonhardt et al., 2003; de Mendonça et al., 2009; 
Duarte et al., 2009; Máximo et al., 2009; Heitz-Mayfield et al., 2012) or resective surgical 
procedures (Romeo et al., 2005, 2007; Serino & Turri, 2011; de Waal et al., 2013). Regard-
less of technique, the majority of surgical protocols included administration of periopera-
tive or postoperative systemic antibiotics (Behneke et al., 2000; Leonhardt et al., 2003; 
Romeo et al., 2005; 2007; Roos Jansåker et al., 2007; 2011; 2014; Roccuzzo et al., 2011; 
Serino & Turri, 2011; Aghazadeh et al., 2012; Heitz-Mayfield et al., 2012; Wiltfang et al., 
2012). However, as concluded in a consensus report from the 8th European Workshop on 
Periodontology, (Sanz & Chapple, 2012), the influence of the adjunctive use of systemic 
antibiotics on treatment outcome is still unknown. Thus, adequately powered randomized 
controlled trials are of  high priority (Berglundh & Giannobile, 2013). 
In study IV, a randomized controlled clinical trial, the effect of the local use of chlor-
hexidine for implant surface decontamination in surgical treatment of peri-implantitis was 
investigated and the outcome of surgical therapy of peri-implantitis with and without sys-
temic antibiotics evaluated.
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Aims
The current series of studies has a translational profile and aims at characterizing peri-
implantitis lesions and improving methods in treatment of  the disease. 
The specific aims were:
- to analyze the tissue reactions following ligature removal in experimental periodontitis 
and peri-implantitis in dogs. (Study I)
- to examine differences in cellular characteristics of human peri-implantitis and periodon-
titis lesions. (Study II)
- to evaluate the effect of surgical treatment of experimental peri-implantitis at implants 
with different surfaces characteristics using different anti-infective procedures. (Study 
III)
- to investigate the adjunctive effect of systemic antibiotics and local use of chlorhexidine 
for implant decontamination on surgical treatment of  peri-implantitis. (Study IV)
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Material & methods
Animal studies (Study I and III) – Study protocol
The protocol of each experiment was approved by the regional Ethics Committee for 
Animal Research, Göteborg, Sweden (approval Dnr 181-2006 and Dnr 221-2009, respec-
tively). The experiments were conducted at the Laboratory of Experimental BioMedicine 
at the Sahlgrenska Academy, University of  Gothenburg in 2007 and 2011 respectively. 
Two groups of 6 destination-bred Labrador dogs about 1,5 year old were used. The ani-
mals were fed a soft diet during the experiment. The outline of study I and III are de-
picted in Figure 1. 
Figure 1. Schematic view of  the outline of  the pre-clinical in vivo studies.
General anesthesia
During all surgical procedures general anesthesia was induced with intravenously injected 
Propofol (10mg/ml, 0.6ml/kg) and sustained with N2O:O2 (1:1.5-2) and Isoflurane em-
ploying endo-tracheal intubation. 
Implant placement
The mandibular premolars and the first molar and the three anterior premolars of the 
maxilla were extracted in all dogs on the right side in study I and bilaterally in study III. 
Three months later, 4 implants were placed in a randomized order in the edentulous pre-
molar area of  the mandible. (Figure 2)
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Figure 2. Design of  the pre-clinical in vivo studies.
In study I, 4 implants with similar geometry and with two different surface characteristics 
(MKIII NP, 3.3 x 10 mm, Nobel Biocare AB, Göteborg, Sweden / implant A; turned sur-
face and implant B; TiUniteTM surface) were placed pair-wise in the right side of the man-
dible. One dog developed Adisson’s disease and was euthanized 2 months after implant 
installation.
In study III, 4 implants with different surface characteristics were used: implants A, B and 
C had the dimension 3.5 x 11mm (ASTRA TECH Implant SystemTM, Dentsply Implant, 
Mölndal, Sweden) and presented respectively a TiOblastTM surface (implant A), an Osseo-
speedTM surface (implant B) and a AT-I surface (Johansson et al., 2012) (implant C). Im-
plant D had the dimension 3.3 x 11.5mm with a TiUniteTM surface (NobelBiocare AB, 
Göteborg, Sweden). The sequence of implant placement was identical in both sides of 
each animal but randomized between animals.
Experimental periodontitis and peri-implantitis
Three months after implant installation, experimental peri-implantitis was initiated around 
all implants in both experimental studies. In study I, experimental periodontitis was also 
initiated around the 4th, 3rd and 2nd premolars in the left side of the mandible. Plaque 
control procedures were abandoned and cotton ligatures were placed in a sub-gingival 
position around teeth and in a corresponding position around the neck portion of the 
implants in a manner previously described (Lindhe et al. 1992, Zitzmann 2004).  
The ligatures were removed and a new  set of ligatures was placed in a more apical position 
at all sites after 3 weeks. The ligature shift procedure was repeated 3 weeks later and the 
ligatures were finally removed at 9 weeks (study III) and 10 weeks (study I) after the initia-
tion of  the experimental breakdown. 
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Spontaneous progression of experimental periodontitis and peri-
implantitis (Study I)
After ligature removal, plaque accumulation was allowed during a subsequent 26-week 
period. 
Surgical treatment of  experimental peri-implantitis (Study III)
Oral hygiene procedures were re-instituted at all implants immediately after ligature re-
moval. Treatment of peri-implantitis was performed at all implants four weeks later.  No 
systemic antibiotics were administrated. The treatment included open flap debridement/
decontamination of the implant. Two different implant surface decontamination proce-
dures, saline (control group) or a 0.2 % solution of chlorhexidine digluconate (test group), 
one on each side of the mandible, were randomly and equally allocated in a split-mouth 
design. Thus, full-thickness flaps were raised on the buccal and lingual aspects of all im-
plants and the inflamed tissue within the crater-formed bone defects was removed. If pre-
sent, calculus was removed from the implant surface by the use of curettes. In one side of 
the mandible, the implants were carefully cleaned for 3 minutes by sterile 10 x 10 mm 
gauze soaked in saline, while in the contralateral side cleaning of implants was performed 
using sterile 10 x 10 mm gauze soaked in a 0.2% solution of chlorhexidine digluconate. 
The flaps were repositioned and sutured. The sutures were removed after 2 weeks and 
mechanical infection control procedures were re-instituted and maintained during the sub-
sequent 6-month period of  the experiment.
Radiological and clinical examination
For all animals, radiological and clinical examinations of tooth and implant sites were per-
formed during the active breakdown period and at ligature removal. A set of radiographs 
was obtained from tooth and implant sites using a customized film holder (Kerr Hawe, 
Bioggio, Switzerland) as previously described by Persson et al. (1999) and Albouy et al. 
(2009, 2011). 
In study I, radiographs were obtained 10, 16 and 26 weeks after ligature removal (base-
line). In study III, clinical and radiological examinations were performed and repeated at 2 
weeks (baseline) and 2, 3, 4 and 6 months after surgery. 
Microbiological sampling (Study III)
In study III, microbiological samples were obtained from all experimental peri-implantitis 
sites 4 weeks after ligature removal and at 3 and 5 months of  follow-up. 
Cotton rolls were used to isolate the experimental areas to avoid saliva contamination. 
Supra-gingival plaque was removed by a sterile gauze soaked in saline. Four sterile medium 
sized paper points (Dentsply, Maillefer, size 35, Ballaigues, Switzerland) were inserted into 
the most apical part of the peri-implant pocket and held in place for 10 seconds. The pa-
per points were removed and placed in Eppendorf tubes (Starlab, Ahrensburg, Germany) 
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and prepared for microbiological analysis (checkerboard DNA-DNA hybridization 
technique).
Biopsy procedure
26 weeks after ligature removal (study I) or after peri-implantitis surgery (study III), the 
dogs were euthanized with a lethal dose of Sodium-Pentothal® (Hospira Enterprises B. V., 
Hoofddorp, Netherlands) and perfused through the carotid arteries with a fixative (4 % 
formaldehyde). The mandibles were retrieved, and tissue blocks from tooth- and implant 
sites were dissected using a diamond saw  (Exakt, Kulzer, Norderstedt, Germany) and 
stored in the fixative. 
In study I, two blocks were produced from the tooth site of the mandible: one posterior 
block containing the 4th premolar and the distal root portion of the 3rd premolar and one 
anterior block containing the 2nd premolar and the mesial root portion of the 3rd premo-
lar. Using a randomization protocol, 50 % of the tissue blocks from tooth and implant 
sites were processed for ground sectioning according to the methods described by Donath 
& Breuner (1982) while the remaining samples were decalcified and embedded in paraffin 
(tooth sites) or further prepared according to the “fracture-technique” (implant sites) 
(Berglundh et al., 2004) and embedded in paraffin.
In study III, all tissue specimens were processed for ground sectioning. 
Human biopsy samples and clinical study (Study II and 
IV) - Study protocol
The protocols of study II and IV were approved by the regional Ethics Committee, Göte-
borg, Sweden (approval Dnr 245-10 and Dnr. 654-10, respectively). All subjects were in-
formed about the study, given a detailed description of the procedure and signed a written 
consent.
Power calculation 
In study II, for superiority of peri-implantitis lesions in relation to periodontitis lesions, 
with an α  of 0.05, a given standard deviation of 1.8 %, and a power of 80 %, a difference 
in area proportions of cells of 3 % required a sample size of 30 subjects in each group. 
To compensate for possible complications during histological processing, the number of 
recruited patients was 40 for each group. 
In study IV, sample size calculation was based on a difference of PPD reduction between 
groups of 0.5 mm with a standard deviation (S.D.) of 0.5 mm, a significance level of 5 % 
and 80 % power. The required sample size was 20 subjects for each treatment group. 
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Study II
Two groups of patients from one clinic in periodontics, Mölndal, Public Dental Health 
Services, Region Västra Götaland, Sweden, were included. One group consisted of 40 
patients with generalized severe chronic periodontitis (24 women and 16 men; age range, 
40-89 year; mean, 64 ± 11.45 year). The patients exhibited bone loss ≥ 50 % and probing 
pocket depth ≥ 7 mm with bleeding on probing at ≥  4 teeth. A second group of 40 pa-
tients presenting with severe peri-implantitis was also recruited (23 women and 16 men; 
age range, 46-93 year; mean, 70 ± 10.41 year; function time for implants, 2-10 year). The 
subjects in this group demonstrated at least 1 implant with peri-implant bone loss ≥ 3 mm 
and a peri-implant probing pocket depth ≥ 7 mm, with bleeding on probing and/or sup-
puration. 
None of the subjects had a known systemic disorder that could have affected the perio-
dontal and peri-implant tissue conditions. Smoking habits were recorded in both groups. 
No patients had received any treatment regarding periodontal or peri-implant diseases 
during the last 6 months.
Biopsy procedures
Diseased interproximal tooth/implant sites were identified that exhibited probing pocket 
depth ≥ 7 mm with bleeding on probing. Following local anesthesia (Xylocain Dental 
Adrenalin, 20 mg/mL + 12.5 µg/mL; Dentsply Pharmaceutical, York, PA, USA), 2 parallel 
incisions, 4 mm apart, were made with a 12D scalpel blade (Hu-Friedy®, Chicago, IL, 
USA) through the soft tissue until bone contact was achieved. The 2 incisions were con-
nected with a perpendicular incision placed at a distance of 4 mm from the tooth/implant. 
The biopsies, including the entire supracrestal soft tissue portion of the diseased site, were 
carefully retrieved, mounted in mesh basquets (Tissue-Tek® Paraform® Sectionable Cas-
sette System, Inc. Sakura Finetek Europe, The Netherlands) and placed in 4 % buffered 
formalin for 48h. The samples were stored in 70 % ethanol and kept at 4°C.
Study IV
The study was registered at ClinicalTrials.gov (NCT01857804). CONSORT guidelines for 
clinical trials were followed and the study flow chart is presented in Figure 3.
The study population consisted of 100 patients (35 males and 65 females; mean age 66.3 
± 13.6 years) presenting with severe peri-implantitis at one or more implants (i.e. peri-
implant probing pocket depth ≥6 mm on at least one aspect of the implant, together with 
bleeding and/or suppuration on probing (BoP and/or SoP positive) and radiographically 
documented marginal bone loss of  >3 mm). 
The patients were referred to two specialist clinics in periodontics (Mölndal and 
Gothenburg, Public Dental Health Services, Region Västra Götaland, Sweden) and were 
enrolled between October 2010 and December 2013. 
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Exclusion criteria were compromised general health, treatment with systemic antibiotics 
during the past 6 months and a known allergy to penicillin.
Baseline examination and randomization procedure
In the baseline examination, the following variables were recorded at the mesial, distal, 
buccal and lingual aspects of each implant: probing pocket depth (PPD) measured with a 
manual periodontal probe (Hu-Friedy®, Chicago, IL, USA), BoP/SoP within 15 seconds 
following pocket probing.
Patients were randomly allocated to four treatment groups using computer-generated lists: 
Group 1 (systemic antibiotics/implant surface decontamination with antiseptic agent) 
(n=27), Group 2 (systemic antibiotics/implant surface decontamination with saline) 
(n=25), Group 3 (no systemic antibiotics/implant surface decontamination with antiseptic 
agent) (n=24) and Group 4 (no systemic antibiotics/implant surface decontamination with 
saline) (n=24). 
The allocation procedure was stratified for smokers/non-smokers. Demographic data of 
the patient sample are presented in Table 5. The distribution of implant-categories with 
regard to surface characteristics between treatment groups is depicted in Table 6. 24 % of 
all implants had a non-modified surface (category A). In patient groups 1 and 2, the 10-day 
systemic antibiotic regimen (amoxicillin 2 x 750mg daily) commenced 3 days prior to sur-
gery. In patient groups 1 and 3 an antiseptic agent (0.2 % solution of chlorhexidine diglu-
conate) was applied for implant surface decontamination during surgery. 
Microbiological sampling and analysis
Samples from the subgingival microbiota were obtained at implant sites targeted for surgi-
cal therapy. The area of the sites chosen for sampling was isolated with cotton rolls, dried 
and supra-gingival plaque was removed with sterile cotton pellets. 6 sterile paper points 
(Dentsply, Maillefer, size 35, Ballaigues, Switzerland) were inserted to the most apical part 
of the peri-implant pocket, kept in place for 10s and then placed in two different tubes for 
culture and checkerboard DNA–DNA hybridization analysis, respectively.  
Surgical procedure
Prior to surgery, patients were enrolled in a hygiene program including professional su-
pragingival implant/tooth cleaning using rubber cups, polishing paste and oral hygiene 
instructions. The surgical procedure was aiming at pocket elimination using resective tech-
niques. Screw-retained supra-constructions were removed. Following local anesthesia, full 
thickness flaps were elevated on the buccal and lingual aspects of affected implants. In-
flamed tissue was removed and titanium-coated curettes (Hu-Friedy®, Chicago, IL, USA) 
were used to remove hard deposits on implants.
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Figure 3. CONSORT flow chart of  the study. 
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Table 5. Demographic data on patients.
All groups Group 1
(AB+/AS+)
Group 2
(AB+/AS-)
Group 3
(AB-/AS+)
Group 4
(AB-/AS-)
Number of  patients 100 27 25 24 24
Age 
years; mean (range) 66.3 (21-90) 65.7 (23-90) 67.9 (21-88) 64.6 (27-81) 66.9 (30-88)
Gender
n (%)
Male 35 7 (25.9) 8 (32) 10 (41.7) 10 (41.7)
Female 65 20 (74.1) 17 (68) 14 (58.3) 14 (58.3)
Smoking habits
n (%)
Smoker 33 9 (33.3) 9 (36) 8 (33.3) 7 (29.2)
Non-smoker 67 18 (66.7) 16 (64) 16 (66.7) 17 (70.8)
History of  periodontitis
n (%) 84 21 (77.8) 21 (84) 21 (87.5) 21 (87.5)
Diabetes
n (%) 5 2 (7.4) 0 1 (4.2) 2 (8.3)
CVD-related drug therapy
n (%) 31 9 (33.3) 8 (32) 6 (25) 8 (33.3)
CVD: Cardiovascular disease
Table 6. Characteristics of  affected implants.
All groups
Group 1
(AB+/AS+)
Group 2
(AB+/AS-)
Group 3
(AB-/AS+)
Group 4
(AB-/AS-)
Number of  implants presenting with peri-
implantitis (range) 179 (1-7) 47 (1-5) 46 (1-6) 49 (1-7) 37 (1-6)
Jaw
n (%)
Maxilla
116 (64.8) 35 (74.5) 28 (60.9) 32 (65.3) 21 (56.8)
Mandible
63 (35.2) 12 (25.5) 18 (39.1) 17 (34.7) 16 (43.2)
Location
n (%)
Anterior
(incisor-canine) 91 (50.8) 25 (53.2) 23 (50) 26 (53.1) 17 (45.9)
Posterior 
(premolar- molar) 88 (49.2) 22 (46.8) 23 (50) 23 (46.9) 20 (54.1)
Implant surface
category
n (%)
Non-
modified
A 43 (24) 3 (6.4) 12 (26.1) 15 (30.6) 13 (35.1)
Modified
All 
modified 136 (76) 44 (93.6) 34 (73.9) 34 (69.4) 24 (64.9)
B 87 30 21 26 10
C 9 2 2 1 4
D 24 7 6 4 7
E 13 5 5 1 2
F 3 0 0 2 1
A : Turned surface (Nobel Biocare AB, Göteborg, Sweden); B : TiUnite surface (Nobel Biocare AB, Göteborg, 
Sweden); C : TiOblast surface (Astra Tech Implant SystemTM, Dentsply Implant IH AB, Mölndal, Sweden); D : 
Osseospeed surface (Astra Tech Implant SystemTM, Dentsply Implant IH AB, Mölndal, Sweden); E : SLA surface 
(Straumann, Institute Straumann, Basel, Switzerland), F : Neoss ProActive surface (Neoss Ltd., Harrogate, UK).
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Implant surfaces were decontaminated with 10 x 10 mm gauze soaked in either a 0.2 % 
solution of chlorhexidine digluconate (groups 1 and 3) or saline (groups 2 and 4) for 2 
minutes. Osseous recontouring was performed when indicated. The flaps were closed with 
interrupted sutures and supra-constructions were reconnected. Patients rinsed for 1 min-
ute with 0.2 % chlorhexidine solution twice daily for 14 days following surgery. Sutures 
were removed two weeks after surgical therapy and self-performed mechanical infection 
control procedures were initiated. Intra-oral radiographs were obtained using the long-
cone paralleling technique and a Dürr Dental digital radiography sensor (Dürr Dental AG, 
74321 Bietigheim-Bissingen, Germany) with sensor holder (Eggen-holder or Super-bite 
blocks, Kerr Dental / Kerr Corporation, Orange, CA, USA).
Evaluation at 6 and 12 months following treatment
During the 12-month follow-up period supra-gingival polishing was performed and oral 
hygiene reinforced, if indicated, in a 3-month interval. Microbiological samples were taken 
at 3, 6 and 12 months after surgery. At 6 and 12 months, clinical assessments of PPD, BoP 
and SoP were performed. In addition, new intra-oral radiographs were obtained at the 12-
month examination. Adverse events throughout the study period were also recorded. 
Radiological analysis
Study I and III 
The radiographs were analyzed in an Olympus SZH10 stereo macroscope (Olympus opti-
cal co, GmbH, Hamburg, Germany) and digital images were obtained with a Leica 
DFC280 camera (Leica, GmbH, Wetzlar, Germany). Calibration of the measurements was 
performed using a millimeter ruler. The abutment-implant junction at implant sites and 
the cemento-enamel junction at tooth sites were used as reference landmarks for the ra-
diographic measurements. The vertical distance between the reference landmark and the 
marginal bone level was assessed at the mesial and distal aspects of each implant/tooth 
using the QWin software (Leica Qwin Standard V3.2.0, Leica Imaging Systems Ltd., Cam-
bridge, U.K.).
Study IV
The radiographs were analyzed with an image-software (ImageJ64, National Institutes of 
Health, Bethesda, MD, USA). The known inter-thread pitch distance of the implant was 
used in each radiograph for the calibration of the coronal-apical measurements. The mar-
ginal bone level was assessed at the mesial and distal aspects of each implant at x 10 mag-
nification on a high definition monitor. All radiologic assessments were performed by one 
investigator (OC). 
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Histological processing and analysis
Ground sectioning (Study I and III)
The tissue blocks selected for ground sectioning were dehydrated in increasing grades of 
ethanol and embedded in Technovit 7200 VLC-resin (Kulzer, Friedrichsdorf, Germany) 
and prepared as described previously (Albouy et al., 2012). From each block (tooth and 
implant), 2 parallel sections were obtained in a mesio-distal plane and 2 parallel sections 
obtained in a bucco-lingual plane. The sections were reduced by microgrinding (Exakt, 
Apparatebau, Norderstedt, Germany) to a final thickness of about 30 µm and stained in 
toluidine blue and fibrin stain of Ladewig (Donath & Breuner, 1982). All sections were 
exposed to histometric analysis.
The histological examinations were performed in a Leica DM-RBE microscope (Leica, 
Heidelberg, Germany) equipped with an image system (Q-500 MC, Leica, Wetzlar, Ger-
many). The following landmarks were identified and used for the linear measurement: the 
gingival/peri-implant mucosa margin (GM/PM), the abutment–fixture junction (A/F) at 
implant sites, the cemento-enamel junction (CEJ) at tooth sites, the apical termination of 
the biofilm (aPlaque) on the implant/tooth surface, the apical termination of the pocket 
epithelium (aPE), the marginal position of bone closest to the implant/tooth (B), the most 
coronal extension of the bone crest (BC) and the coronal and apical extension of the infil-
trated connective tissue (cICT and aICT ).  
In study I, the distance between the ICT and the lateral bone wall of the intra-bony de-
fects (ICT-Bw) was measured in three locations; coronal, middle, apical. The surface area 
of the ICT (ICT area) in the connective tissue was evaluated by outlining its circumfer-
ence.
In study III, when indicated, areas of the residual intra-bony defect (defined by the bone 
wall between B and BC) and of an ICT were identified and traced. The occurrence of the 
ICT was scored as follows:
- Score 0: no or only scattered inflammatory cells identified in an area < 1 mm2
- Score 1: scattered inflammatory cells located in an area < 2 mm2
- Score 2: clusters of  inflammatory cells presented in infiltrates of  a total area < 3 mm2
- Score 3: abundance of  inflammatory cells in a total ICT area >3 mm2
Paraffin-embedded preparation (Study I and II)
Tissue samples that included the implant and the surrounding soft and hard peri-implant 
tissues (study I), were placed in EDTA and subsequently processed using “the fracture-
technique” as described by Berglundh et al. (1994). The specimens were dehydrated and 
embedded in paraffin (study I and II). Microtome serial sections (5µm thick) were cut and 
mounted on glass poly-D-lysine-coated slides. 
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In study I, sections from the implant units were produced parallel with the long axis of the 
implant, while the tooth units were sectioned in a mesio-distal (P2-P3 or P3-P4) and a 
bucco-lingual plane (mesial root of P2 or distal root of P4). The paraffin-embedded sec-
tions were processed for immunohistochemical preparation.
Immunohistochemistry (Study I and II)
The panel of  monoclonal antibodies that were used is presented in Table 7.
Table 7. The panel of  antibodies used for the immunohistochemical analysis.
Antibodies
Clone
Specificity
Dilutions
Study I Study II Study I Study II
CD3 rabbit mouse T-cells 1:200 1:50
CD20 rabbit mouse B-cells 1:800 1:400
CD34 mouse endothelial cells 1:100
CD68 mouse macrophages 1:200
CD138 mouse plasma cells 1:50
MPO rabbit rabbit polymorphonuclear leukocytes 1:1000 1:1500
IgG rabbit IgG-positive cells (plasma / B cells) 1:100
In study I, the enzymatic activity of tartrate resistant acid phosphatase (TRAP; acid phos-
phatase, leukocyte kit, Sigma-Aldrich Inc., St. Louis, MO, USA) was used as a marker for 
osteoclasts.
The sections were de-waxed and incubated in antigen retrieval solution (DIVA; Biocare 
Medical, Concord, CA, USA) at 60°C over night and subsequently incubated with primary 
antibodies for 30 minutes. The specimens were then incubated with a characterized and 
diluted mouse or rabbit primary antibody, followed by a labeled polymer for 30 minutes 
and a substrate/chromogen for 10 minutes. Counterstaining was performed with hema-
toxylin. Finally, the sections were mounted and coverslipped. Human oral mucosa tissue 
sections were used in Study II as positive controls, while negative controls were produced 
by substituting the primary antibody with non-immune serum.
The surface area of the infiltrated connective tissue (area ICT) was evaluated by outlining 
its circumference. The histological quantitative assessments of cell markers were per-
formed using a microscope equipped with an image system (Leitz DM-RBE Q-500 MC® 
image system, Leica, Wetzlar, Germany). For the identification of positive cell markers, an 
interference contrast setting at a magnification of x 400 was applied as previously de-
scribed (Liljenberg et al., 1994; Zitzmann et al., 2001). A point counting procedure was 
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used to determine the percentage of positive cell markers within the ICT. A lattice com-
prising 400 points was superimposed over the tissue area. Cross points that indicated the 
positive cell markers in the compartment to be examined were counted and related to the 
total counts for the entire ICT (%) and expressed as area proportions (%) of  ICT. 
In study I, the number of TRAP-positive cells within a 200 µm-wide zone immediately 
lateral to the bone crest was assessed. The number of TRAP-positive cells/mm in contact 
with the bone crest was also determined.
In study II, in addition for the point counting procedure, the mean size of positive cells 
was assessed in 10 randomly selected sections of each category of markers in both patient 
groups. Based on the data on cell density, size of ICT and cell size, the total number of 
positive cells for each marker in the ICT was estimated. The density of vascular structures 
of the ICT was determined using the point counting procedure and the endothelial marker 
CD34. The density of vascular units was performed in a 200-μm-wide zone of the con-
nective tissue immediately lateral to the ICT. 
Microbiological processing and analysis
Checkerboard DNA-DNA hybridization technique (Study III and 
IV)
Microbial samples scheduled for checkerboard DNA–DNA hybridization were placed in 
sterile Eppendorf tubes and analyzed according to the checkerboard methodology  (So-
cransky et al., 1994), as modified by Papapanou et al. (1997). They were transferred to 100 
µl TE buffer (10 mM Tris HCl, 1 mM EDTA, pH 7.6) and 100 µl 0.5 M NaOH was added 
and the suspensions boiled for 5 min. After boiling, 800 µl 5 M ammonium acetate was 
added to each tube and the samples were processed according to standardized procedures. 
The checkerboard panel included 10 dogs strains (Pasteurella stomatis, Porphyromonas sp, Por-
phyromonas cangingivalis, Porphyromonas crevioricanis, Porphyromonas gulae, Tannerella forsythia 
(dog), Peptostreptococcus canis, Filifactor villosus, Campylobacter oricanis) and two human strains 
(Prevotella intermedia, Treponema denticola) in study III. In study IV, the panel included 12 hu-
man strains (Aggregatibacter actinomycetemcomitans, Campylobacter rectus, Filofactor alocis, Fusobacte-
rium. nucleatum, Parvimonas micra, Prevotella intermedia/Prevotella nigrescens, Prevotella tannerae, 
Porphyromonas endodontalis, Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola). The 
hybrids formed between the bacterial DNA and the probes were detected by application 
of an antidigoxigenin antibody conjugated with alkaline phosphatase and incubation with 
a chemiluminiscent substitute (CSPD; Boehringer-Mannheim, Phoenix, AZ, USA). 
The obtained chemiluminiscent signals were transformed into a scale of scores from 0 to 
5 according to Papapanou et al. (1997): score 0 (no detected signal), score 1 and 2 (signal ≤ 
105 bacteria) and score 3, 4 and 5 (signal > 105 bacteria).  The total DNA-probe count was 
calculated by summing the absolute counts of  the separate probes included in the panel.
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Culture technique (Study IV) 
Microbial samples scheduled for culture were placed in glass bottles containing 3.3 ml 
VMGA III (Dahlén et al., 1993) and transported to the laboratory for analysis. After mix-
ing a volume of 0.1 ml of the concentrated transport medium to 1:100 and 1:10,000 times 
dilution in VMGA III, bacteria were plated onto the surface of an enriched Brucella blood 
agar plate (BBL; Microbiological System, Cockeysville, MD, USA). The agar plates were 
incubated anaerobically in jars using the hydrogen combustion method (Möller & Möller, 
1961) at 37°C for 6–8 days for calculating the total viable count (TVC). Porphyromonas gin-
givalis was distinguished from Prevotella intermedia/nigrescens by its haemagglutinating activity 
and lack of auto-fluorescence in UV light (Slots and Genco, 1979; Slots and Reynolds, 
1982). Blood agar (Difco), Staphylococcus agar (Difco), Enterococcus agar (BBL) and 
tryptic soy serum bacitracin vancomycin agar plates (BBL) were inoculated and incubated 
for 2 and 5 days, respectively, at 37°C in air with 10 % CO2. Special attention was given to 
Staphylococcus aureus, Staphylococcus  epidermidis, enterococci and aerobic Gram-negative bacilli 
(AGNB). S.aureus was distinguished from S.epidermidis by performing DNase test on spe-
cial DNA agar plate (Difco). The plates were examined for typical colony morphology and 
the specific bacteria were registered as percentage of  TVC.  
The cut-off score for this semi-quantification were based on a previously published study 
(Charalampakis et al., 2012) and a 5-graded scale was used to frame the magnitude of bac-
teria (Aggregatibacter actinomycetemcomitans, Campylobacter rectus, Fusobacterium nucleatum, Porphy-
romonas gingivalis, Prevotella intermedia/nigrescens, Staphylococcus aureus, Staphylococcus epidermidis, 
enterococci, AGNB) as proportions of TVC (Dahlén et al 1982): score 0: non-detectable 
growth of colonies, score 1: <0.1% TVC, score 2: 0.1–1% TVC, score 3 (moderate growth 
of  colonies): 1–10% TVC and score 4: >10% TVC (heavy growth of  colonies).
Error of  methods
For accuracy assessments of the radiological, histological and immunohistochemical analy-
ses, double measurements were performed in all studies. (Table 8)
Table 8. Inter- and intra-examiner variations.
Inter-examiner variation
mean (S.D.)
Intra-examiner variation
mean (S.D.)
Radiological analysis : radiographs (60 % in study I, 40 % in study III, 30 % in study IV) were randomly selected and double assessments performed 
with a 2-month interval.
Study I 0.28 mm (±0.24) 0.42 mm (±0.32)
Study III 0.06 mm (±0.11)
Study IV 0.37 mm (±0.49) 0.35 mm (±0.22)
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Table 8. Inter- and intra-examiner variations.
Inter-examiner variation
mean (S.D.)
Intra-examiner variation
mean (S.D.)
Histological analysis : in randomly chosen sections (25 % in study I and III), one parameter of  each assessment category was randomly selected and 
re-measured.
Study I
PM/aJE 0.12 mm (±0.13) 0.15 mm (±0.13)
ICT area 0.75 mm2 (±0.48) 0.21 mm2 (±0.19)
Study III
aJE/B 0.18 mm (±0.17)
ICT area 0.13 mm2 (±0.27)
Immunohistochemical analysis : in randomly selected sections ( 45 % in study I, 12 % in study II), the area proportions of  cells markers in the ICT 
were re-assessed. The intra-examiner variations were expressed as mean % (S.D.) on average for cell markers.
Study I 0.45 % (±0.41)
Study II 0.79 % (±0.56)
Data analysis
The SPSS 21.0 software package (SPSS 21.0 software package, SPSS Inc., Chicago, Illinois, 
USA) was used for all statistical analysis. 
Study I and III
Mean values for all variables were calculated for each implant/tooth unit in each animal. 
Using the animal as the statistical unit, differences were analyzed using analysis of variance 
(ANOVA) and the Student–Newman–Keuls test. A p-value <0.05 was considered as 
significant. A statistical package specially designed for multilevel modeling (MLwiN 2.28; 
Center for Multilevel Modelling at University of Bristol, Bristol, UK) was used to investi-
gate the influence of dogs, implant/tooth, sites and implant surface-related covariates on 
the outcome variables.
Study II
Mean values and standard deviations were calculated for each variable and patient. 
Differences between patient groups were analyzed with the Student’s t-test for unpaired 
observations (n = 80). The null hypothesis was rejected at p < 0.05. Analysis of covariance 
was performed to analyze possible effects of  gender, age and smoking on the results.
Study IV
Clinical variables at baseline, 6 and 12 months were expressed in mean values and fre-
quency distributions. Differences were analyzed using analysis of variance, Chi-Square 
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(between groups) and McNemar analysis (within groups). A p-value <0.05 was considered 
as significant. 
Implant sites presenting with PPD ≤ 5mm, absence of BoP and SoP at the 12 months 
examination and bone loss ≤ 0.5 mm between 2 weeks and 12 months after surgical 
therapy, were considered as treatment success and the primary outcome variable. To iden-
tify factors affecting the probability of treatment success, a binary logistic regression was 
used. The independent factors examined included treatment factors, patient-related data 
(age, gender, smoking habits, history of periodontitis, systemic disorder), implant-related 
data (number of affected implants, jaw  and location). Implants were further categorized 
according to surface characteristics (non-modified and modified). All variables were tested 
by the Wald test in a bivariate analysis and statistically significant variables (p<0.05) were 
retained in the multiple model. The two treatment factors were forced into the final model 
and possible interaction between factors was explored. Results were expressed as odds 
ratios (OR) including 95 % confidence intervals.
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Results
Comparison peri-implantitis/periodontitis (Study I and II)
Radiological findings (Study I)
The mean bone loss that took place during the active breakdown period was significantly 
greater at both types of implants than at teeth (2.69 ± 0.57 mm for implants in group A, 
3.14 ± 0.69 mm for implants in group B and 1.74 ± 0.53 mm for teeth).
The amount of bone loss that occurred during the 26-week period between ligature re-
moval and biopsy is illustrated in Figure 4. The differences between implant B and implant 
A and between implant B and teeth were statistically significant. Multilevel modeling re-
vealed that neither animal nor implant position in the mandible influenced results.
Figure 4. Radiographical bone level changes after ligature removal.
† p-value<0.05 between tooth and implant B; ‡ p-value<0.05 between implant A and implant B
Histological findings (Study I) 
Tissues samples from the experimental model provided access to the entire lesion, includ-
ing soft and hard tissues.
The examination of the supra-crestal soft tissues portion revealed signs of established 
disease with greater loss of connective tissue attachment and larger area of ICT in peri-
implantitis than in periodontitis lesions. An intact epithelial apical seal and a zone of 
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structurally intact and non-inflamed connective tissue was consistently present between 
the apical border of the ICT and the alveolar bone crest in tooth sections.  At implant 
sites, in the contrary, no epithelial barrier was present and the ICT extended to the bone 
crest.
The examination of the peri-implant tissues revealed an extensive osseous defect, the sur-
face of which was lined with large, multi-nuclear cells. Such cells were only occasionally 
identified at the alveolar bone surface in the tooth sections.
Results from the histometric measurements at tooth and implant sites are depicted in Fig-
ure 5. Overall, vertical dimensions of the pocket epithelium (GM/PM-aPE) and the ICT 
(cICT-aICT) were significantly larger at implants than at teeth. These dimensions were, in 
addition, also significantly larger at implants type B than at implants type A. Similar 
differences were also found with regard to the size of ICT (ICT area), which was 
significantly closer to the bone (aICT-B) at implants than at teeth. Size and vertical dimen-
sion of  the intra-bony component was significantly larger at implant B than at implant A.
Immunohistochemical findings (Study I and II)
Common markers for Study I and II
The results from the immunohistochemical analysis are illustrated in Table 9. 
Table 9. Size (mm2) and area proportions of ICT for positive cells in periodontitis and peri-
implantitis sites.
Study I Study II
Periodontitis
(n=10)
Peri-implantitis
Periodontitis
(n=40)
Peri-implantitis 
(n=40)Implant A
(n=10)
Implant B
(n=10)
Area (mm2)
ICT area
0.42 (±0.28) #,† 1.98 (±1.54) # 2.30 (±0.95) † 1.49 (±1.05) 3.48 (±2.54) *
Cell markers
CD3 (%) 5.39 (±3.92) 5.78 (±2.11) 7.08 (±3.42) 7.82 (±5.36) 6.87 (±4.42)
CD20 (%) 4.42 (±4.02) 2.61 (±2.82) 1.81 (±1.54) 4.97 (±5.23) * 3.10 (±2.79)
MPO (%)
2.72 (±1.49) #,† 8.53 (±5.71) †,‡ 13.26 (±5.81) †,‡ 4.28 (±2.52) 10.90 (±7.53) *
# p-value<0.05 between tooth and implants A; † p-value<0.05 between tooth and implants A; 
‡ p-value<0.05 between implant A and implants B; * p-value<0.05 between human periodontitis and peri-
implantitis sites
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Figure 5. Results from the histometric measurements at tooth and implant sites. Mean values.
*p-value<0.05 between tooth and implant A; † p-value<0.05 between tooth and implant B; ‡ p-value<0.05 between 
implant A and implant B.
In both study I and II, the size of ICT in the peri-implantitis specimens was significantly 
larger than that of the lesions in the periodontitis sections. The area proportion of the 
ICT that was occupied by MPO-positive cells was significantly larger in peri-implantitis 
than in periodontitis specimens in the experimental and the human biopsy study. The den-
sity of CD20-positive cells was larger in periodontitis than peri-implantitis lesions in the 
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human material of study II. No difference were observed between groups regarding CD3-
positive cells.
TRAP-positive cells (Study I)
The total number of TRAP-positive cells/mm was substantially larger at peri-implantitis 
(3.62 ± 3.72 cells/mm for implant A, 6.88 ± 5.73 cells/mm for implant B) than at perio-
dontitis sites (0.74 ± 1.24 cells/mm). The difference in numbers of TRAP cells/mm 
between implant type B and teeth was statistically significant.
CD138-, CD68-positive cells and vascular structures (Study II)
The area proportions of the ICT that was occupied by CD138- and CD68-positive cells 
was significantly larger in peri-implantitis (13.24 ± 9.22 %, and 3.68 ± 3.53 %, respec-
tively) than in periodontitis specimens (8.96 ± 6.71 %, and 2.13 ± 3.17 %, respectively). 
The density of vessels within the ICT was significantly larger in periodontitis (7.81 ± 5.09 
%) than in peri-implantitis (2.75 ± 2.60 %). In the connective tissue portion lateral to the 
ICT, however, the proportion of vascular structures was significantly larger in peri-
implantitis (8.58 ± 8.93 %) than in periodontitis (2.31 ± 2.34 %). In addition, the 
differences in vascular density between the two tissue compartments were statistically 
significant for both periodontitis and peri-implantitis specimens.
Total number of  cells and cells/mm2  (Study II)
The percentage distribution of total number of cells in ICT of periodontitis and peri-
implantitis lesions with the relative overall size of the ICT is presented in Figure 6. The 
large discrepancy on the overall size of the ICT between the 2 types of specimens is also 
illustrated in Figure 6.
Figure 6. Percentage distribution  of total number of cells in  periodontitis and peri-implantitis lesions. 
(n=80) *p-value<0.05 between periodontitis and peri-implantitis lesions.
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The results from the assessments of cell size, the calculated total number positive cells, 
and number of cells/mm2 within the ICT are illustrated in Figure 7. The estimated total 
number of inflammatory cells within ICT was significantly larger in peri-implantitis than 
in periodontitis sections. The numbers of CD3-, CD138-, CD68-, and MPO-positive cells 
were significantly larger in peri-implantitis than in periodontitis lesions. 
Figure 7. Total estimated number and density of positive cells in the ICT of periodontitis (n=40) and 
peri-implantitis (n=40) sites. *p-value<0.05 between periodontitis and peri-implantitis lesions.
The overall density of inflammatory cells within the ICT (i.e., the number of cells/mm2) 
was significantly higher in peri-implantitis than in periodontitis specimens. Specifically, the 
densities of CD138-, CD68-, and MPO-positive cells were significantly higher in peri-
implantitis than in periodontitis lesions, whereas an opposite association was observed for 
CD20-positive cells.
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The largest total number of cells or cells/mm2 among the different phenotypes was found 
for MPO- and CD138-positive cells in peri-implantitis lesions. These two cell categories in 
peri-implantitis not only occurred in 3- to 6-times larger numbers than their counterparts 
in periodontitis lesions but also outnumbered other cell groups in both types of  lesions.
The ANCOVA analysis of patient characteristics revealed that differences in the distribu-
tion of gender, age and smokers between the periodontitis and the peri-implantitis groups 
did not influence the results from the immunohistochemical assessment.
Treatment of  peri-implantitis (Study III and IV)
Radiological findings
Preparatory period of  ligature-induced breakdown (Study III)
The amount of bone loss that occurred during the preparatory period of ligature-induced 
breakdown varied between 3.57 and 3.73mm. (Table 10). 
Table 10. Radiographical bone level alterations during the preparatory period prior to treatment. Mean 
values (±S.D.)
Implant A Implant B Implant C Implant D
Bone level changes during the preparatory period before surgical 
treatment (mm)
-3.58 (±0.76) -3.72 (±0.65) -3.73 (±0.47) -3.57 (±0.63)
Period after surgical treatment of  peri-implantitis (Study III and IV)
Three months after the peri-implantitis surgery, one implant B representing the test group 
was lost and the radiologic bone loss around this implant was assessed to the apical exten-
sion of the implant. The results from the radiological assessments are presented in Table 
11. 
In study III, in the control group (saline), radiographic bone gain was observed after sur-
gical treatment at implants of type A and type C while additional bone loss was observed 
at implants of type B and type D. Bone loss at implant type D was significantly larger than 
at implant types A, B and C. In the test group (chlorhexidine), only implants of type C 
presented radiographic bone gain during the corresponding period, while additional bone 
loss was observed at implants of types A , B and D. The radiological analysis failed to 
demonstrate statistically significant differences between test and control procedures.
In study IV, bone gain was observed at implants in patients of groups 1 and 2, while addi-
tional bone loss was noted in the other two groups.
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Table 11. Results from radiological examination after surgical treatment. Mean values (±S.D.)
Study III All implants Implant A Implant B Implant C Implant D
Bone level changes between 2 weeks and 
6 months after surgery (mm)
Control
(saline) - 0.52 (±2.09) 0.37 (±2.02) - 0.20 (±1.88) 0.51 (±1.24) - 2.77 (±1.58) *
Test
(chx) - 0.27 (±1.85) - 0.46 (±1.39) - 0.18 (±2.64) 0.73 (±0.81) - 1.15 (±2.01)
Study IV All groups Group 1(AB+/AS+)
Group 2
(AB+/AS-)
Group 3
(AB-/AS+)
Group 4
(AB-/AS-)
Bone level changes between 2 weeks and 12 months after 
surgery (mm) -0.21 (±1.32) 0.18 (±1.15) § 0.51 (±0.84) § - 0.69 (±1.32) § - 0.96 (±1.42) §
 * p-value <0.05 implant D vs. implants A, B and C; § p-value <0.05 Groups 1 and 2 vs. Groups 3 and 4
Clinical findings
Study III
One implant B representing the test group was lost three months after the peri-implantitis 
surgery. During the period following surgical therapy clinical signs of inflammation in the 
peri-implant mucosa gradually resolved and towards the end of the experiment the major-
ity of sites demonstrated absence of clinical signs of inflammation. At implants type D of 
the control group (saline), however, swelling and redness persisted in the peri-implant mu-
cosa.
Study IV
Three patients (2 patients in group 3 and 1 patient in group 4) did not attend the 
examination at 6 months after surgery but attended the final examination (12 months). 
One patient with one affected implant and representing group 3, did not attend the 
examination at 6 and 12 months. All patients in groups 1 and 2 reported complete adhe-
sion to the systemic antibiotic regimen. Five of these patients reported mild gastro-
intestinal problems. During the 1-year follow-up period, 6 implants in 6 patients were 
found to be disintegrated and, hence, removed (group 1: 1 implant/1 patient, group 3: 3 
implants/3 patients, and group 4: 2 implants/2 patients). All lost implants had a modified 
surface.
The results from the clinical assessments are presented in Table 12. Reduction in PPD 
occurred in all treatment groups but was significantly larger in group 2 than in groups 3 
and 4 at the 1-year examination. At 6 months following the surgical treatment of peri-
implantitis, BoP remained at 53 % of affected implants. Further improvement (42%) was 
observed at 12 months, with no significant differences between treatment groups. At 12 
months, SoP was observed at 18 % of  all sites (Figure 8).
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Table 12. Results from clinical examinations. Baseline (n=179) and changes at 6 (n=174) and 12 
months (n=172) after surgical treatment. Mean values (±S.D.)
All groups
Group 1
(AB+/AS+)
Group 2
(AB+/AS-)
Group 3
(AB-/AS+)
Group 4
(AB-/AS-)
Baseline probing pocket depth, 
at deepest site (mm) 7.82 (±1.52) 7.85 (±1.57) 7.93 (±1.50) 7.79 (±1.69) 7.78 (±1.25)
Probing depth 
changes (mm)
Baseline to 6 months -2.71 (±1.71) -3.03 (±1.58) # -3.49 (±1.54) † -2.18 (±1.54) † -1.95 (±1.81) #†
Baseline to 1 year -2.58 (±1.97) -2.80 (±1.87) -3.44 (±1.66) † -2.16 (±1.79) † -1.69 (±2.22) †
# p-value<0.05 Group 1 vs. Group 4; † p-value<0.05 Group 2 vs. Groups 3 and 4.
Treatment success was obtained at 45 % of all implants at 12 months after surgical 
therapy. The corresponding value assessed at the patient level was 38 % (Figure 9). The 
results from the analysis of treatment success indicated different outcomes between im-
plant surface categories. Thus, treatment success was obtained overall in 79.1 % of im-
plants and in 66.7 % of patients representing implant surface category A (non-modified 
surface). The corresponding data for implants with modified surfaces (categories B, C, D, 
E and F) were 34.1 % and 32.5 %, respectively. In addition, the absence of the adjunctive 
use of systemic antibiotics or local antiseptics had minor effect on treatment success for 
implant category A. In implant category B, however, no cases exhibited treatment success 
in the absence of  systemic antibiotics (treatment groups 3 and 4). 
The results from the logistic regression analysis are shown in Table 13. 
Table 13. Factors associated with treatment success: logistic regression analysis. 
OR CI (95%) p
Antibiotics No 1 - -
Yes 0.55 0.11 - 2.72 0.462
Antiseptics
No 1 - -
Yes 0.634 0.30 - 1.32 0.221
CVD-related drug therapy No 1 - -
Yes 0.21 0.09 - 0.48 <0.001
Implant surface modification Non-modified 1 - -
Modified 0.032 0.01 - 0-115 <0.001
Interaction
Antibiotics (Yes) x Implant 
surface modification 
(Modified)
15.1 2.37 - 95.7 <0.001
CVD : Cardiovascular Diseases
The adjunctive use of systemic antibiotics and local antiseptics had no impact on treat-
ment success (OR 0.55; p=0.46 and OR 0.63; p=0.22 respectively), while CVD-related 
drug therapy had a negative effect (OR 0.21; p<0.0001).
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Figure 8. Proportions of implants exhibiting BoP and SoP (%) at baseline (n=179), at  6 (n=174) and 
1 year (n=172) after surgical treatment.
* p-value <0.05 Group 2 vs. Groups 3 and 4.
Figure 9. Proportions (%) of  treatment success at implant level (n=178) and patient level (n=99).
AB+/AS-AB+/AS+all groups AB-/AS+ AB-/AS-
Implant level (n=178)
Patient level (n=99)
Treatment success
all groups AB+/AS+ AB+/AS- AB-/AS+ AB-/AS-
Non
modified
surface
Modified
surface
45
40
65
67
38 35
38 37
56
30 29
Non
modified
surface
Modified
surface
79
34
33
Using implant with a non-modified surface (category A) as a reference, implants with 
modified surfaces (categories B, C, D, E and F) showed a significantly lower OR for treat-
ment success (OR 0.032; p<0.0001). Interaction between the use of antibiotics and surface 
characteristics was observed in the data analysis, indicating a positive effect of the adjunc-
tive use of systemic antibiotics in treatment of peri-implantitis around implants with 
modified surfaces (OR 15.1; p=0.004). 
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Histological findings (Study III)
Gross observations
At control sites, the peri-implant mucosa around implants A and C exhibited a thin barrier 
epithelium, apical of which a non-inflamed connective tissue was facing the implant sur-
face. Scattered inflammatory cells were occasionally found in the marginal portion of the 
connective tissue around the implants A and C. The majority of control specimens 
representing implant B exhibited clusters of inflammatory cells of varying size in the mar-
ginal portion of the peri-implant connective tissue. All implants D exhibited no signs of 
resolution of peri-implantitis characterized with an extensive osseous defects and a large 
inflammatory cell infiltrates in the surrounding connective tissue.
At test sites, the peri-implant mucosa around implants B and C exhibited a barrier epithe-
lium of varying length, apical of which a fibrotic connective tissue portion was observed, 
the majority of specimens representing implant A and D presented with inflammatory 
cells residing in the connective tissue compartment lateral and apical to the barrier/pocket 
epithelium.
Histometric measurements 
Among the control group specimens, the residual bony defect area at implants of type D 
was significantly larger than that of  implants A, B and C (Figure 10).
The overall distribution of the ICT scores differed between the test and control groups 
(Figure 11). While in implants B, C and D the test procedure resulted in lower scores than 
the control procedure, a reverse relationship was found for implants A. Marked 
differences in score distribution were also detected between the implant types. Thus, in the 
test group 5 out of 6 implants of type C and 4 out of 6 implants of type B exhibited an 
ICT score 0, whereas the majority of implants of type A and D presented with a score 3. 
In the control group the largest proportion of implants with score 0 was found among 
implants A, while 83 % of  implants D had an ICT score 3. 
Microbiological findings (Study III, IV)
Study III
In terms of total count of bacteria, no statistically significant differences were observed 
among implants prior to surgery. The total count, however, had decreased significantly at 3 
and 5 months after surgery in both test and control groups, except for implants D. An 
increase of the total DNA-probe counts occurred at implant D of the control groups 
(Table 14).
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Figure 10. Residual intrabony defect area representing control (saline) and test (chlorhexidine) procedures 
for implants type A, B, C, D. (n=6)
* p-value <0.05 between implant D versus implant A, B and C of  the control group.
Figure 11. ICT score for control (saline) and test (chlorhexidine) sites at implant type A, B, C, D.
Score 0 (green), 1 (blue), 2 (orange), 3 (brown).
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Statistically significant differences in DNA-probe counts were observed between implant 
C and D both at 3 and 5 months. No statistically significant differences were found 
between test and control sites for any of  the implant types. 
Table 14. Changes in total DNA-probe counts (x105) at control (saline) and test (chlorhexidine) groups 
for each implant type from surgery to 3 and 5 months after surgery. Mean values (S.D.) (n = 6)
Total DNA-probe 
counts changes (x105)
Implant A Implant B Implant C Implant D
Control
(saline)
Test
(Chx)
Control
(saline)
Test
(Chx)
Control
(saline)
Test
(Chx)
Control
(saline)
Test
(Chx)
Day of  surgery - 
3 months
after surgery
-4.77 * -4.49 * -9.99 * -6.93 * -10.4 * -15 * 7.46 -6.54
Day of  surgery - 
5 months
after surgery
-5.8 * -9.97 * -10.83 * -11.69 * -12.6 * -14.9 * 5.23 -3.47
*: p-value <0.05 between baseline versus 3 and 5 months for implant A, B, C 
Study IV
The results microbiological analysis are reported in Figure 12. The overall profile of 
changes in total DNA counts was similar for the 4 treatment protocols and exhibited a 
significant decline during the 12-month period after surgical therapy. The total viable 
counts also decreased after surgery in all treatment groups. 
Checkerboard and culture analysis showed that Fusobacterium nucleatum and Prevotella 
intermedia/nigrescens were the most common type of bacteria presenting moderately heavy/
heavy growth at baseline (71 % and 46 % of the patients, respectively) and 1 year after 
surgical treatment (54 % and 43 % of the patients, respectively). Moderately heavy/heavy 
growth of Staphylococcus aureus was detected in one patient before surgery, but never at the 
1-year examination. No patient presented with moderately heavy/heavy growth of Aggre-
gatibacter actinomycetemcomitans. Detailed data from checkerboard and culture analysis are 
presented in Table 15.
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Figure 12. Mean total DNA-probe counts changes (x105) and mean Total Viable Counts changes 
(x107) after surgical treatment of peri-implantitis for each treatment group. Significant decrease of total 
DNA-probe counts after surgery in all treatment groups.
Table 15. Percentage of  patients with not detected and detected bacteria (by checkerboard/culture analysis) 
before and 1 year after surgical treatment.
DNA-DNA checkerboard
Species
Culture
Signal > 105 bacteria 
(score 3, 4, 5)
No detected signal
(score 0)
Not detected
(score 0)
Detected in moderately heavy/
heavy amounts (score 3, 4)
Before surgery 1 year Before surgery 1 year Before surgery 1 year Before surgery 1 year
0 0 92 94 A.a 100 98 0 0
0 1 41 48 C.rectus 54 63 30 22
73 36 0 2 F.nucleatum 17 31 71 54
7 3 74 77 P.gingivalis 87 91 10 7
48 19 33 60
P.intermedia/
P.nigrescens 37 39 46 43
S.aureus 97 100 1 0
S.epidermidis 80 75 0 5
Enterococci 96 98 2 2
AGNB 88 82 10 18
1 0 78 75 F.alocis
4 4 42 48 P.endodontalis
3 2 6 12 P.micra
1 1 69 61 P.tannerae
2 2 45 50 T.denticola
4 4 31 40 T.forsythia
AGNB : Aerobic Gram-negative bacilli
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Main findings
- Spontaneous progression of experimental peri-implantitis resulted in greater amount of 
bone loss, larger inflammatory cell infiltrates with larger proportions of neutrophil granu-
locytes and osteoclasts than experimental periodontitis. (Study I)
- Human peri-implantitis lesions were more than twice as large and contained significantly 
larger area proportions, numbers and densities of CD138-, CD68- and MPO-positive 
cells than human periodontitis lesions. (Study II)
- The local use of chlorhexidine has minor influence on resolution of peri-implantitis 
following surgical treatment. (Study III)
- Implant surface characteristics influence treatment outcomes. (Study III and IV)
- The adjunctive use of systemic antibiotics increased the probability for treatment success 
at implants with modified surfaces but not at implants with a non-modified surface. 
(Study IV)
Main findings
59

Concluding remarks
The current series of studies employed a translational approach in the comparison 
between peri-implantitis and periodontitis lesions and the evaluation of surgical treatment 
of  peri-implantitis. 
Translational research
Translational research is an important aspect of research, bringing together findings from 
pre-clinical in  vivo studies to subsequent clinical implementation. Thus, when adequately 
designed and conducted, pre-clinical in  vivo research provides important information that 
adds to our understanding in the pathogenesis and treatment of peri-implantitis. The dog 
experiments used in this series of experiments are suitable pre-clinical models to study 
peri-implantitis. Dogs exhibit a natural susceptibility to periodontal disease (Gad, 1968; 
Lindhe et al., 1973, 1975; Kortegaard et al., 2008) and jaw  bone anatomy in dogs allows 
the placement of commercially available dental implants (Grunder et al., 1993; Wetzel et 
al., 1999; Nociti Júnior et al., 2001; Shibli et al., 2003; Albouy et al., 2008; Schwarz et al., 
2011).
While studies using animal models are an important part of dental research, the translation 
of results into therapeutic strategies for humans is far from straightforward. The validity 
of an animal model is judged in terms of similarities between the model and the human 
condition to be studied. Thus, an animal model is considered as valid in the presence of 
similarities with the human condition in terms of aetiology, physiopathology and response 
to therapeutic interventions (Bhogal & Balls, 2008). Evidence of validity is usually divided 
into three aspects: predictive validity (effective interventions in the animal model demonstrate 
a similar effect clinically), face validity (similarities in pathogenesis between the disease in the 
animal model and the human condition) and construct validity (a factor evaluated in the ex-
periment has a similar role in the disease model as in the clinical situation) (Denayer et al., 
2014).
Pathogenesis of  peri-implantitis
An analysis of the pathogenesis of peri-implantitis and periodontitis in humans has its 
limitations. The biopsy-sampling procedure should ideally include the harvesting of the 
entire lesion together with the supra-crestal soft tissue portion and the crestal bone. From 
an ethical point of view, sampling of human biopsies is often restricted to the soft tissue 
component, as the supporting bone can not be retrieved. Animal models have been used 
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in pre-clinical in vivo  studies, providing access to the entire disease process, including both 
soft and hard tissues.
Study I demonstrated that more bone loss occurred at peri-implantitis than at periodontitis 
sites during the period following ligature removal. The histological analysis revealed that 
peri-implantitis specimens exhibited lesions that were larger, extended closer to the bone 
crest and contained larger proportions of neutrophil granulocytes and osteoclasts than 
periodontitis lesions. The radiological and histological findings presented in study I are in 
agreement with observations made by Lindhe et al. (1992). Cotton ligatures were placed 
around teeth and implants in five beagle dogs and plaque was allowed to accumulate. 
While the ligatures were removed after 6 weeks, plaque formation continued and after an 
additional 4-week period clinical and radiological examinations were performed and block 
biopsies were obtained. It was reported that clinical signs of inflammation and radio-
graphic bone loss were more pronounced at peri-implantitis than at periodontitis sites. 
Similar findings were presented by Schou et al. (1993), who compared a 7-week period of 
ligature-induced breakdown around implants as well as ankylosed and non-ankylosed teeth 
in monkeys. The authors reported that bone loss was more pronounced around implants 
than teeth and that bone loss was associated with a high number of osteoclasts in the his-
tological specimens. While Schou et al. (1993) and Lindhe et al. (1992) studied lesions in 
peri-implant and periodontal tissues resulting from subgingival plaque formation in the 
presence of cotton ligature and one month after ligature removal, the experiment in study I 
applied the modified ligature-model introduced by Zitzmann et al. (2004) and tissue reac-
tions to plaque formation were analyzed at 6 months following the removal of  ligatures.
While quantitative analysis of experimentally induced disease was performed in study I, 
qualitative evaluations of cells involved in human peri-implantitis and periodontitis lesion 
were addressed in study II. Thus, the analyses of human specimens in study II demonstrated 
that peri-implantitis lesions were more than twice as large and contained significantly 
larger area proportions, numbers and densities of CD138 (plasma cells)-, CD68 (macro-
phages)- and MPO (neutrophiles granulocytes)-positive cells than periodontitis lesions. 
The findings on differences in size of the lesions between the two conditions reported are 
in agreement with results from study I, thus pointing to the validity of the experimental 
model. There are few  reports on human peri-implantitis lesions. Sanz et al. (1991) analyzed 
soft tissue biopsies from 6 patients with peri-implantitis and reported that about 2/3 of 
the connective tissue portion of the biopsies were occupied by an infiltrate consisting of 
plasma cells, mononuclear cells and enlarged blood vessels. Berglundh et al. (2004) ana-
lyzed soft tissue biopsies obtained from 12 implant sites with severe peri-implantitis in 6 
patients. The histological analysis demonstrated that the lesions occupied almost the entire 
connective tissue compartment and extended apical to the pocket epithelium. It was also 
observed that the lesions contained not only plasma cells and lymphocytes but also PMN 
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cells in high numbers, which were residing in peri-vascular compartments distant from the 
“pocket area”. These data are consistent with results obtained both in study II and study I.
The examination of the two types of lesions in study II is relevant in regards to similar 
appraisals of differences between lesions in varying forms of periodontal diseases. 
Thorbert-Mros et al. (2014) analyzed gingival biopsies from patients with either severe 
generalized periodontitis or longstanding gingivitis. It was reported that periodontitis le-
sions were twice as large and contained significantly larger densities of cells positive for 
the markers CD138 and CD68 than gingivitis lesions. The authors concluded that the large 
number and high density of plasma cells were the hallmarks of advanced periodontitis 
lesions and the most conspicuous difference in relation to longstanding gingivitis lesions. 
Gualini & Berglundh (2003) evaluated differences between peri-implant mucositis and 
peri-implantitis lesions. The authors examined immunohistochemical characteristics of 
soft tissue biopsies obtained from 16 patients and reported that peri-implantitis lesions 
contained significantly greater proportions of B cells and elastase-positive cells (indicating 
PMN cells) than mucositis lesions. Thus, the severity of a condition appears to correlate 
with the size of the lesion and a cell profile with enhanced densities and numbers of the 
B-cell /plasma cell line together with neutrophil granulocytes and macrophages. Peri-
implantitis lesions carry such characteristics.
Considering differences in numbers and densities of CD138-, CD68-, and MPO-positive 
cells between peri-implantitis and periodontitis lesions, it was emphasized in study II that 
the inflammatory response at peri-implantitis sites was stronger by promoting cells, which 
are part of both the innate and the adaptive host response. Studies on gene expression of 
pro-inflammatory markers at periodontitis and peri-implantitis sites (Venza et al.,2010; 
Becker et al.,2014) presented similar findings. However, it should be noted that the analy-
ses performed by Venza et al. (2010) and Becker et al. (2014) were not restricted to the 
inflammatory lesions as the processing included the entire soft tissues biopsy.
Treatment of  peri-implantitis
A review of the current literature reveals that many pre-clinical in  vivo experiments and 
clinical studies have been performed on the treatment of peri-implantitis. However, as 
reported by Faggion et al. (2011) and Graziani et al. (2012), there is a large variation 
among clinical studies in terms of design (case series, controlled clinical trials, randomized 
control trials), sample size (ranging from 9 to 45 patients), follow-up (ranging from 3 
months to 4 years) and type of intervention (different decontamination procedures and/
or bone augmentation procedures). Moreover, Claffey et al. (2008) concluded in a review 
that access surgery combined with implant surface decontamination for treatment of peri-
implantitis had rarely been investigated in a controlled manner. The authors also reported 
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that a great variation existed in terms of use and regimen of systemic antibiotics (alone or 
in combination with other antimicrobial agents) both in pre-clinical in  vivo  and clinical 
studies. Adjunctive systemic antibiotics has been used in many clinical trials (Behneke et 
al., 2000; Leonhardt et al., 2003; Romeo et al., 2005, 2007; Roos Jansåker et al., 2007, 2011, 
2014; Roccuzzo et al., 2011; Serino & Turri, 2011; Aghazadeh et al., 2012; Heitz-Mayfield 
et al., 2012; Wiltfang et al., 2012; Serino et al., 2014;), but no study evaluated their adjunc-
tive benefit. As resolution of peri-implantitis following surgical therapy without adjunctive 
use of systemic antibiotics has been demonstrated in pre-clinical in vivo studies (Schwarz et 
al., 2006; Shibli et al., 2006, Albouy et al., 2011), randomized and controlled clinical trials 
in patients with peri-implantitis are ethically justified. At the 8th European Workshop of 
Periodontology, Sanz & Chapple (2012) emphasized the need for parallel-arm randomized 
controlled studies, including a large sample size and at least 1 year follow-up, for evaluating 
the adjunctive effect of systemic antibiotics on surgical treatment of peri-implantitis. Simi-
lar statement were made in a consensus report on prevention and management of biologic 
and technical implant complications (Heitz-Mayfield & Mombelli, 2014). Study IV reports 
on a 1-year follow-up of 100 patients enrolled in a prospective randomized controlled 
clinical trial, designed to investigate the effect of adjunctive systemic antibiotics on surgical 
treatment of peri-implantitis. As recommended by Sanz & Chapple (2012), treatment suc-
cess were defined using a composite outcome of disease resolution, including PPD ≤ 
5mm, absence of bleeding/suppuration at the 12-month examination and bone loss ≤ 
0.5mm between 2 weeks and 12 months after surgical therapy.
Conclusions regarding the influence of implant surface characteristics on treatment out-
come of surgical therapy of peri-implantitis revealed in study IV validate observations 
made in the pre-clinical study III. Results from the longitudinal assessments of bone level 
changes in radiographs as well as microbiological and histological analyses in study III 
demonstrated lower occurrence of resolution of peri-implantitis at implants with a Ti-
Unite surface (corresponding to implants of type D) when compared to implants with 
TiOblast, Osseospeed and AT-1 surfaces. This observation was confirmed by the results 
reported in study IV where implants with a TiUnite surface (corresponding to implants of 
category B in study IV) exhibited the smallest overall frequency of treatment success. 
Albouy et al. (2011), in a pre-clinical experiment and Roccuzzo et al. (2011) in clinical 
study also concluded that treatment outcomes of surgical therapy of peri-implantitis were 
influenced by implant surface characteristics. Albouy et al. (2011) examined radiologic and 
histological outcomes following surgical treatment of peri-implantitis in dogs. Experimen-
tal peri-implantitis was induced around different types of implants (Turned, SLA, TiOblast 
and TiUnite). Surgical therapy included mechanical cleaning of implants and was per-
formed without using adjunctive systemic antibiotics or local antiseptics. Resolution of 
inflammation as observed in histological analysis was obtained from implants with non-
modified and with TiOblast surfaces. In addition, the assessments of bone level changes in 
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radiographs during the 6-month healing period revealed bone gain at implants with non-
modified surfaces and at two of the implant categories with modified surfaces (TiOblast 
and SLA), whereas bone loss occurred at implants with a TiUnite surface. Roccuzzo et al. 
(2011) evaluated the treatment of peri-implantitis around implants with either a rough 
(TPS) or a moderately rough (SLA) surface in 26 patients. One year follow-up demon-
strated that the surgical therapy was more effective in reducing PPD, BoP and bone de-
fects at implants with moderately rough surfaces. 
The differences in resolution of peri-implantitis lesions at different implant types ob-
served in study III and IV might be related to the difficulties of decontaminating exposed 
implant surfaces. A number of different decontamination protocols including the use of 
chemical agents, air-abrasives or lasers, have been presented in pre-clinical in  vivo studies 
and clinical trials. Gauzes soaked in chlorhexidine or saline were commonly used and the 
two detergents were applied either alone or in combination. Wetzel et al. (1999) in a dog 
study, analyzed treatment of experimental peri-implantitis using 0.12 % solution of chlor-
hexidine digluconate to decontaminate implant surfaces and reported that bone fill oc-
curred in the osseous defects around all types of implants following therapy. In a dog 
study aiming to evaluate differences in bone fill and re-osseointegration at implants with 2 
different surfaces, Persson et al. (2001) reported resolution of peri-implantitis lesions 
following the local use of pellets soaked in saline at both types of implants. Similar results 
were reported in a study performed in dogs by You et al. (2007), who combined both 
chlorhexidine and saline in the cleaning of implant surfaces. These findings are in agree-
ment with study III, which failed to demonstrate that chlorhexidine had any major effect on 
treatment outcomes but reported that resolution of peri-implantitis following surgical 
treatment was possible by using a gauze soaked in saline to decontaminate implant sur-
faces. The observed lack of benefit of the local use of chlorhexidine on treatment out-
come reported in study III is validated by findings made in study IV. In a randomized con-
trolled clinical study with 1, 2 and 4 years follow-up, Schwarz et al. (2011, 2012, 2013) 
evaluated the impact of two surface decontamination methods (Er-YAG laser versus plas-
tic curets + cotton pellets soaked in sterile saline) on the clinical outcomes of combined 
surgical treatment of peri-implantitis. Both treatment regimens resulted in similar and sta-
tistically significant short-term clinical improvement and radiographic bone fill. After a 
follow-up period of 2 and 4 years, the authors concluded that treatment outcomes in sur-
gical therapy of advanced peri-implantitis were not influenced by the method of surface 
decontamination. De Waal et al. (2013) evaluated in a randomized, double-blind, placebo-
controlled trial the effect of implant surface decontamination with chlorhexidine/
cetylpyridinium chloride on microbiological and clinical parameters. Thirty patients (79 
implants) with peri-implantitis were treated with resective surgical treatment. The use of 
the combined detergents resulted in greater immediate suppression of anaerobic bacteria 
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than the placebo procedure, but did not result in superior clinical outcomes at 1 year. 
These findings partly confirm data presented in the study III and IV.
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